Electroconvulsive Therapy for a Patient with Suicide by Drinking Bleach During Treatment of COVID-19: A Case Report

AuthorValiollah Hassanien
AuthorSaied Amniatien
AuthorFatemeh Kashaninasaben
AuthorMohammad Niakanen
AuthorOmid Moradi Moghadamen
AuthorAli Akbar Jafarianen
AuthorReza Farahmand Raden
AuthorSaloome Sehat-Kashanien
AuthorAzadeh Habibien
OrcidSaied Amniati [0000-0002-2128-2540]en
OrcidMohammad Niakan [0000-0001-7602-0305]en
OrcidOmid Moradi Moghadam [0000-0003-4152-7397]en
OrcidReza Farahmand Rad [0000-0003-2783-6652]en
OrcidSaloome Sehat-Kashani [0000-0003-3207-7777]en
Issued Date2020-12-08en
AbstractElectroconvulsive therapy (ECT) was first experienced in 1938 and had been conducting without anesthesia for 30 years. In this study, the most common indication for ECT was mood disorder (major depressive disorder and bipolar I disorder). We introduce a patient with a history of COVID-19 and suicide who required emergency ECT. Electroconvulsive therapy can be life-saving in patients with suicide history or catatonic schizophrenia. Health workers are at the front line of the COVID-19 outbreak control and must follow health instructions. Aerosol-producing procedures such as suction in anesthesia for ECT may facilitate the transmission of infectious diseases such as COVID-19. When performing aerosol-producing procedures during the pandemic of novel coronavirus, every patient should be considered suspicious.en
DOIhttps://doi.org/10.5812/aapm.107513en
KeywordElectroconvulsive Therapyen
KeywordCOVID-19en
KeywordSuicideen
KeywordSARS-CoV-2en
PublisherBrieflandsen
TitleElectroconvulsive Therapy for a Patient with Suicide by Drinking Bleach During Treatment of COVID-19: A Case Reporten
TypeCase Reporten

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
aapm-10-6-107513.pdf
Size:
953.31 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF